Uncategorized

7 FDA decisions to watch for in Q3

Published

on

Many of the FDA’s decisions this quarter involve applications that have previously been delayed, declined or outright rejected, including one for an mRNA vaccine that became the center of controversy earlier this year.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version